Adalimumab biosimilars have similar efficacy to originator adalimumab when treating non-infectious uveitis
27.07.2025 | Tomkins-Netzer O, Niederer RL, Amer R, Sar S, Gepstein R, Habot-Wilner Z, Shyriaieva H, Diab R, Brodie J, Corredores J, Rozanes E, Cohen S, Barnett-Griness O, Lightman S, Kramer M, Sharon Y
Br J Ophthalmol. 2025 Jul 11:bjo-2025-327767. doi: 10.1136/bjo-2025-327767